Rationale and design of a cluster randomized trial of a multifaceted intervention in people with hypertension: The Heart Outcomes Prevention and Evaluation 4 (HOPE-4) Study
Background: Cardiovascular disease is the leading cause of death throughout the world, with the majority of deaths occurring in low- and middle-income countries. Despite clear evidence for the benefits of blood pressure reduction and availability of safe and low-cost medications, most individuals ar...
Published in: | American Heart Journal |
---|---|
Main Author: | Schwalm J.-D.R.; McCready T.; Lamelas P.; Musa H.; Lopez-Jaramillo P.; Yusoff K.; McKee M.; Camacho P.A.; Lopez-Lopez J.; Majid F.; Thabane L.; Islam S.; Yusuf S. |
Format: | Article |
Language: | English |
Published: |
Mosby Inc.
2018
|
Online Access: | https://www.scopus.com/inward/record.uri?eid=2-s2.0-85049739079&doi=10.1016%2fj.ahj.2018.06.004&partnerID=40&md5=8b777861100b7372c3eed5a998e22c35 |
Similar Items
-
Novel Approaches in Primary Cardiovascular Disease Prevention: The HOPE-3 Trial Rationale, Design, and Participants' Baseline Characteristics
by: Lonn E.; Bosch J.; Pogue J.; Avezum A.; Chazova I.; Dans A.; Diaz R.; Fodor G.J.; Held C.; Jansky P.; Keltai M.; Keltai K.; Kunti K.; Kim J.-H.; Leiter L.; Lewis B.; Liu L.; Lopez-Jaramillo P.; Pais P.; Parkhomenko A.; Peters R.J.G.; Piegas L.S.; Reid C.M.; Sliwa K.; Toff W.D.; Varigos J.; Xavier D.; Yusoff K.; Zhu J.; Dagenais G.; Yusuf S.
Published: (2016) -
Rationale, Design and Baseline Characteristics of Participants in the Cardiovascular Outcomes for People Using Anticoagulation Strategies (COMPASS) Trial
by: Bosch J.; Eikelboom J.W.; Connolly S.J.; Bruns N.C.; Lanius V.; Yuan F.; Misselwitz F.; Chen E.; Diaz R.; Alings M.; Lonn E.M.; Widimsky P.; Hori M.; Avezum A.; Piegas L.S.; Bhatt D.L.; Branch K.R.H.; Probstfield J.L.; Liang Y.; Liu L.; Zhu J.; Maggioni A.P.; Lopez-Jaramillo P.; O'Donnell M.; Fox K.A.A.; Kakkar A.; Parkhomenko A.N.; Ertl G.; Störk S.; Keltai K.; Keltai M.; Ryden L.; Dagenais G.R.; Pogosova N.; Dans A.L.; Lanas F.; Commerford P.J.; Torp-Pedersen C.; Guzik T.J.; Verhamme P.B.; Vinereanu D.; Kim J.-H.; Ha J.-W.; Tonkin A.M.; Varigos J.D.; Lewis B.S.; Felix C.; Yusoff K.; Steg P.G.; Aboyans V.; Metsarinne K.P.; Anand S.S.; Hart R.G.; Lamy A.; Moayyedi P.; Leong D.P.; Sharma M.; Yusuf S.
Published: (2017) -
Understanding the modifiable health systems barriers to hypertension management in Malaysia: A multi-method health systems appraisal approach
by: Risso-Gill I.; Balabanova D.; Majid F.; Ng K.K.; Yusoff K.; Mustapha F.; Kuhlbrandt C.; Nieuwlaat R.; Schwalm J.-D.; McCready T.; Teo K.K.; Yusuf S.; McKee M.
Published: (2015) -
Ethyl 4-[(2-hydroxyethyl)amino]-2-(4-methoxy-phenyl)-1-methyl-5-oxo-2,5-dihydro-1H-pyrrole-3-carboxylate
by: Abdul Rashid F.N.A.; Mohammat M.F.; Abdul Manan M.A.F.; Bakhtiar Afendy A.A.A.; Cordes D.B.; McKay A.P.
Published: (2024) -
Innovative Approaches to Hypertension Control in Low- and Middle-Income Countries
by: Vedanthan R.; Bernabe-Ortiz A.; Herasme O.I.; Joshi R.; Lopez-Jaramillo P.; Thrift A.G.; Webster J.; Webster R.; Yeates K.; Gyamfi J.; Ieremia M.; Johnson C.; Kamano J.H.; Lazo-Porras M.; Limbani F.; Liu P.; McCready T.; Miranda J.J.; Mohan S.; Ogedegbe O.; Oldenburg B.; Ovbiagele B.; Owolabi M.; Peiris D.; Ponce-Lucero V.; Praveen D.; Pillay A.; Schwalm J.-D.; Tobe S.W.; Trieu K.; Yusoff K.; Fuster V.
Published: (2017)